Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / vTv Therapeutics
Company

vTv Therapeutics

Tracked across 1 events · 7 articles · First seen Jun 02, 2026 · Last active Jul 02, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 10
Business
vTv Therapeutics Grants Stock Options
Impact: vTv Therapeutics granted stock options to non-executive employees as an inducement for employment, which is a common practice to attract and retain talent. This action could positively impact employee morale and retention, indirectly supporting the company's long-term development goals, especially for its lead drug candidate cadisegliatin.
Jun 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track vTv Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.